Speakers include, Victoria DiBiaso, Head of Protocol Feasibility & Patient Enrolment, Genzyme USA, Kathrin Schoenborn-Sobolewski, Vice President, Clinical Trial Management, Merck Serono, Trond Tennoe, Regional Head, Clinical Operations, Pfizer, Michael Herschel, Director of Clinical Research, GSK, Wolfgang Eglmeier, Head Clinical Operations Germany at Grunenthal and others.
The conference will discuss how the internet is changing the planning and recruiting process around the globe, addressing how technology trends are changing patient behavior and how people are accessing clinical trials. “It is natural that given the explosive growth of social networking sites in Eastern Europe, parts of Latin America, and elsewhere around the globe that part of this conference will examine the changing environment of patient recruitment in pharmaceuticals and biotech.” explains Nick Halkitis, MediciGlobal’s Global Director of eMarketing. “It’s also changing how companies select research sites and in which countries they place their studies.”
Recognized as an opinion leader in patient recruitment, Liz Moench will share insights and expertise related to innovations in patient recruitment, with a focused presentation on how the internet and social networks are changing patient recruitment, patient advocacy and study site selection. Therapeutic case studies and unpublished patient-centric data will be shared with conference executives.
The conference is hosted by the Allan Lloyds Group. To learn more about the 3rd Annual Patient Recruitment and Retention in Pharma Conference in Amsterdam this week, visit www.patientrecruitmentsummit.com.
About MediciGlobal
MediciGlobal is in the business of making a meaningful difference to patient health—by identifying and engaging patients for clinical trials, and by building deep and lasting connections with our many stakeholders. Our clinical trial recruitment practices are guided by global standards and by our concern for the lives of the patients who put their trust in us. We’re also making certain that those who participate in these trials fully understand what clinical trial participation means, and that their participation is guarded by strict privacy policies. MediciGlobal meets BBB OnLine® and WBENC accreditation standards and is certified as a Safe Harbor company. Visit www.mediciglobal.com and follow the company on Facebook at www.facebook.com/MediciGlobal. www.mediciglobal.com
About Allan Lloyds
Allan Lloyds is the world's leading provider of unrivalled high quality business information, that help organizations of all sizes optimize their people and processes, leading to outstanding professional development and superior business results. Our business intelligence is impeccable, with a growing client base made up of international organisations and fortune 500 companies, all leaders within key market sectors.
Allan Lloyds is bringing to the world innovative and viable solutions with a portfolio of different industries, our ability to adapt to change and our foundation of unending quest for perfection has enabled us to become one of the most innovative companies in the information world.
